ProteomicsMultivariate AnalysisProteomePrognosisMass SpectrometryRetrospective StudiesRisk FactorsTandem Mass SpectrometryElectrophoresis, Gel, Two-DimensionalTreatment OutcomeSurvival AnalysisChromatography, LiquidSurvival RateFollow-Up StudiesProspective StudiesPredictive Value of TestsProportional Hazards ModelsTime FactorsTumor Markers, BiologicalLogistic ModelsNeoplasm StagingDisease-Free SurvivalCohort StudiesKaplan-Meier EstimateDatabases, ProteinAge FactorsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBiological MarkersIsotope LabelingProteinsCross-Sectional StudiesAnalysis of VarianceReproducibility of ResultsRegression AnalysisRisk AssessmentCase-Control StudiesProtein Array AnalysisOdds RatioNeoplasm Recurrence, LocalLymphatic MetastasisComputational BiologyBreast NeoplasmsImmunohistochemistrySoftwarePeptidesPrevalenceRecurrenceChi-Square DistributionAlgorithmsSex FactorsIncidenceDisease ProgressionSeverity of Illness IndexGene Expression ProfilingQuestionnairesCombined Modality TherapyUnited StatesSensitivity and SpecificityROC CurvePrincipal Component AnalysisLiver NeoplasmsMetabolomicsAdenocarcinomaSocioeconomic FactorsLung NeoplasmsSequence Analysis, ProteinAntineoplastic Combined Chemotherapy ProtocolsLinear ModelsCluster AnalysisMolecular Sequence DataNeoplasm InvasivenessAmino Acid SequencePostoperative ComplicationsNeoplasm ProteinsGenomicsPeptide MappingTissue Array AnalysisColorectal NeoplasmsComorbidityJapanCarcinoma, HepatocellularEpidemiologic MethodsCarcinoma, Squamous CellModels, StatisticalProtein Processing, Post-TranslationalDiscriminant AnalysisSmokingHIV InfectionsInfant, NewbornSpectrometry, Mass, Electrospray IonizationProbabilityStatistics as TopicRiskData Interpretation, StatisticalFranceNeoplasm MetastasisChemotherapy, AdjuvantDatabases, FactualStomach NeoplasmsBody Mass Index